Prediction of Postprostatectomy Biochemical Recurrence Using Quantitative Ultrasound Shear Wave Elastography Imaging
- PMID: 31338325
- PMCID: PMC6629866
- DOI: 10.3389/fonc.2019.00572
Prediction of Postprostatectomy Biochemical Recurrence Using Quantitative Ultrasound Shear Wave Elastography Imaging
Abstract
Objectives: To determine the prognostic significance of tissue stiffness measurement using transrectal ultrasound shear wave elastography in predicting biochemical recurrence following radical prostatectomy for clinically localized prostate cancer. Patients and Methods: Eligible male patients with clinically localized prostate cancer and extraperitoneal laparoscopic radical prostatectomy between November 2013 and August 2017 were retrospectively selected. Information of potential biochemical recurrence predictors, including imaging (ultrasound shear wave elastography and magnetic resonance imaging), clinicopathological characteristics, and preoperative prostate specific antigen (PSA) levels were obtained. Recurrence-free survival (Kaplan-Meier curve) and a multivariate model were constructed using Cox regression analysis to evaluate the impact of shear wave elastography as a prognostic marker for biochemical recurrence. Results: Patients experienced biochemical recurrence in an average of 26.3 ± 16.3 months during their follow-up. A cutoff of 144.85 kPa for tissue stiffness measurement was estimated for recurrence status at follow-up with a sensitivity of 74.4% and a specificity of 61.7%, respectively (p < 0.05). In univariate analysis, shear wave elastography performed well in all preoperative factors compared to biopsy Gleason Score, PSA and magnetic resonance imaging; in multivariate analysis with postoperative pathological factors, shear wave elastography was statistically significant in predicting postoperative biochemical recurrence, which improved the C-index of predictive nomogram significantly (0.74 vs. 0.70, p < 0.05). Conclusions: The study revealed that quantitative ultrasound shear wave elastography-measured tissue stiffness was a significant imaging marker that enhanced the predictive ability with other clinical and histopathological factors in prognosticating postoperative biochemical recurrence following radical prostatectomy for clinically localized prostate cancer.
Keywords: biochemical recurrence; nomogram; prostate cancer; radical prostatectomy; ultrasound shear wave elastography.
Figures
Similar articles
-
Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?Front Oncol. 2021 Nov 23;11:740724. doi: 10.3389/fonc.2021.740724. eCollection 2021. Front Oncol. 2021. PMID: 34888237 Free PMC article.
-
Performance Characteristics of Transrectal Shear Wave Elastography Imaging in the Evaluation of Clinically Localized Prostate Cancer: A Prospective Study.J Urol. 2018 Sep;200(3):549-558. doi: 10.1016/j.juro.2018.03.116. Epub 2018 Mar 30. J Urol. 2018. PMID: 29605444
-
Quantitative ultrasound shear wave elastography (USWE)-measured tissue stiffness correlates with PIRADS scoring of MRI and Gleason score on whole-mount histopathology of prostate cancer: implications for ultrasound image-guided targeting approach.Insights Imaging. 2021 Jul 8;12(1):96. doi: 10.1186/s13244-021-01039-w. Insights Imaging. 2021. PMID: 34236553 Free PMC article.
-
Characterisation of Prostate Lesions Using Transrectal Shear Wave Elastography (SWE) Ultrasound Imaging: A Systematic Review.Cancers (Basel). 2021 Jan 2;13(1):122. doi: 10.3390/cancers13010122. Cancers (Basel). 2021. PMID: 33558449 Free PMC article. Review.
-
Shear wave elastography in chronic kidney disease - the physics and clinical application.Phys Eng Sci Med. 2023 Dec 11. doi: 10.1007/s13246-023-01358-w. Online ahead of print. Phys Eng Sci Med. 2023. PMID: 38078996 Review.
Cited by
-
Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients.Sci Rep. 2023 Dec 20;13(1):22804. doi: 10.1038/s41598-023-50205-1. Sci Rep. 2023. PMID: 38129557 Free PMC article.
-
Comparative Assessment of Different Ultrasound Technologies in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis.Cancers (Basel). 2023 Aug 15;15(16):4105. doi: 10.3390/cancers15164105. Cancers (Basel). 2023. PMID: 37627133 Free PMC article. Review.
-
Multimodality Characterization of Cancer-Associated Fibroblasts in Tumor Microenvironment and Its Correlation With Ultrasound Shear Wave-Measured Tissue Stiffness in Localized Prostate Cancer.Front Oncol. 2022 Apr 21;12:822476. doi: 10.3389/fonc.2022.822476. eCollection 2022. Front Oncol. 2022. PMID: 35530322 Free PMC article.
-
A Novel Ferroptosis-Based Molecular Signature Associated with Biochemical Recurrence-Free Survival and Tumor Immune Microenvironment of Prostate Cancer.Front Cell Dev Biol. 2022 Jan 6;9:774625. doi: 10.3389/fcell.2021.774625. eCollection 2021. Front Cell Dev Biol. 2022. PMID: 35071228 Free PMC article.
-
Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?Front Oncol. 2021 Nov 23;11:740724. doi: 10.3389/fonc.2021.740724. eCollection 2021. Front Oncol. 2021. PMID: 34888237 Free PMC article.
References
-
- Collette L, Burzykowski T, Carroll KJ, Newling D, Morris T, Schröder FH. Is prostate-specific antigen a valid surrogate end point for survival in hormonally treated patients with metastatic prostate cancer? Joint Research of the European Organisation for Research and Treatment of Cancer, the Limburgs Universitair Centrum, and AstraZeneca Pharmaceuticals. J Clin Oncol. (2005) 23:6139–48. 10.1200/jco.2005.08.156 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
